Search

Author/Creator Mikol, Daniel D

1. A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. (January 2021)

Authors:
Ashina, Messoud; Doležil, David; Bonner, Jo H; Zhou, Lifen; Klatt, Jan; Picard, Hernan; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 41:Number 1(2021)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial. Issue 5 (8th May 2017)

Authors:
Dodick, David; Ashina, Messoud; Kudrow, David; Lanteri-Minet, Michel; Osipova, Vera; Palmer, Kerry; Picard, Hernan; Mikol, Daniel D; Lenz, Robert A
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 88:Issue 5(2017)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study. (September 2018)

Authors:
Ashina, Messoud; Tepper, Stewart; Brandes, Jan Lewis; Reuter, Uwe; Boudreau, Guy; Dolezil, David; Cheng, Sunfa; Zhang, Feng; Lenz, Robert; Klatt, Jan; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 38:Number 10(2018)
Page Start:
1611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study. (June 2019)

Authors:
Goadsby, Peter J; Paemeleire, Koen; Broessner, Gregor; Brandes, Jan; Klatt, Jan; Zhang, Feng; Picard, Hernan; Lenz, Robert; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 39:Number 7(2019)
Page Start:
817
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study. (May 2020)

Authors:
Tepper, Stewart J; Ashina, Messoud; Reuter, Uwe; Brandes, Jan Lewis; Doležil, David; Silberstein, Stephen D; Winner, Paul; Zhang, Feng; Cheng, Sunfa; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 40:Number 6(2020)
Page Start:
543
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine. (October 2019)

Authors:
Ashina, Messoud; Goadsby, Peter J; Reuter, Uwe; Silberstein, Stephen; Dodick, David; Rippon, Gregory A; Klatt, Jan; Xue, Fei; Chia, Victoria; Zhang, Feng; Cheng, Sunfa; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 39:Number 11(2019)
Page Start:
1455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions. (December 2019)

Authors:
Ashina, Messoud; Kudrow, David; Reuter, Uwe; Dolezil, David; Silberstein, Stephen; Tepper, Stewart J; Xue, Fei; Picard, Hernan; Zhang, Feng; Wang, Andrea; Zhou, Yanchen; Hong, Frank; Klatt, Jan; Mikol, Daniel D
Journal:
Cephalalgia
Issue:
Volume 39:Number 14(2019)
Page Start:
1798
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab. (September 2018)

Authors:
Buse, Dawn C; Lipton, Richard B; Hallström, Yngve; Reuter, Uwe; Tepper, Stewart J; Zhang, Feng; Sapra, Sandhya; Picard, Hernan; Mikol, Daniel D; Lenz, Robert A
Journal:
Cephalalgia
Issue:
Volume 38:Number 10(2018)
Page Start:
1622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗